Kessler, R C
Stein, M B
Petukhova, M V
Bliese, P
Bossarte, R M
Bromet, E J
Fullerton, C S
Gilman, S E
Ivany, C
Lewandowski-Romps, L
Millikan Bell, A
Naifeh, J A
Nock, M K
Reis, B Y
Rosellini, A J
Sampson, N A
Zaslavsky, A M
Ursano, R J
Ursano, R J
Stein, M B
Heeringa, S
Kessler, R C
Colpe, L J
Schoenbaum, M
Cersovsky, S
Cox, K
Aliaga, P A
Benedek, D M
Borja, S
Brown, G G
Sills, L C
Dempsey, C L
Frank, R
Fullerton, C S
Gebler, N
Gifford, R K
Gilman, S E
Holloway, M G
Hurwitz, P E
Jain, S
Kao, T-C
Koenen, K C
Romps, L L
Mash, H H
McCarroll, J E
McLaughlin, K A
Naifeh, J A
Nock, M K
Raman, R
Rose, S
Rosellini, A J
Sampson, N A
Santiago, L P
Scanlon, M
Smoller, J
Thomas, M L
Vegella, P L
Wassel, C
Zaslavsky, A M
Mann, J
Oquendo, M
Stanley, B
Posner, K
Keilp, J
,
Article History
Received: 3 February 2016
Revised: 27 May 2016
Accepted: 1 June 2016
First Online: 19 July 2016
Competing interests
: In the past 3 years, Dr Kessler has been a consultant for Hoffman-La Roche and Johnson & Johnson Wellness and Prevention. Dr Kessler has served on advisory boards for Mensante Corporation, Johnson & Johnson Services, Lake Nona Life Project and US Preventive Medicine. Dr Kessler is a co-owner of DataStat. Dr Stein has in the last 3 years been a consultant for Healthcare Management Technologies and had research support for pharmacologic imaging studies from Janssen. The other authors declare no conflict of interest.